BioForce Nanosciences Holdings, Inc. (BFNH) Moves Forward With Uplifting Requirements for OTCQB, Aggressively Pursues Take Over Targets

VIRGINIA BEACH, Va., Oct. 18, 2017 -- BioForce Nanosciences Holdings, Inc. (OTCPINK:BFNH) announces its pursuit to uplift the Company’s tradable common shares onto the OTCQB at OTCMARKETS.COM.

The Company hired new accountants, PCAOB auditors and a securities law firm to assist on the necessary financial disclosures and other related requirements for uplift, OTCQB.

During the last few quarters of operations, BFNH’s management team aggressively looked at a number of unique businesses operations with acquisition intentions.  Due diligence continues on these acquisition “targets” and management believes at least one or more can be acquired.

BFNH management looks at the each target with specific comprehensible modeling, not just limited to goods and services, but includes competition, patents, domestic/international demographics, demand of products/services, outstanding debts/liabilities and other business transparencies.

BFNH will provide more information as the deal-flow becomes more mature.

For further information about this release, contact YES INTERNATIONAL, Investor Relations, 757-306-6090, [email protected] and www.yesinternational.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competitions.

 CONTACT:  BioForce Nanosciences Holdings, Inc. 

                    Rich Kaiser, 757-306-6090